Suchergebnisse - "Capparelli, Edmund V"

PubPharm (43)

1

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA) : a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

enthalten in: The lancet. HIV | 2024

von Lowenthal, E. | Chapman, J. | Ohrenschall, R. | +36

2

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA) : a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

enthalten in: The lancet. HIV | 2024

von Gaur, A. | Capparelli, E. | Calabrese, K. | +40

3

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115) : a phase 1/2 proof-of-concept study

enthalten in: The lancet. HIV | 2024

von Persaud, D. | Bryson, Y. | Nelson, B. | +19

4

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

5

Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients

enthalten in: Pharmacotherapy | 2023

von Salerno, S. | Capparelli, E. | McIlleron, H. | +5

6

Brief Report : Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Ajibola, G. | Maswabi, K. | Hughes, M. | +14

7

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV : Results From IMPAACT P1026s

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Brooks, K. | Pinilla, M. | Stek, A. | +14

8

Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age

enthalten in: AIDS (London, England) | 2022

von Nikanjam, M. | Tran, L. | Chadwick, E. | +11

9

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Momper, J. | Wang, J. | Stek, A. | +13

10

Abacavir dosing in neonates from birth to 3 months of life : a population pharmacokinetic modelling and simulation study

enthalten in: The lancet. HIV | 2022

von Bekker, A. | Capparelli, E. | Violari, A. | +15

CommentIn: Lancet HIV. 2022 Jan;9(1):e3-e4. - PMID 34883067

1
2
3
4
5
Nächster »
[5]